Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 550

1.

Olmesartan/amlodipine: a review of its use in the management of hypertension.

Kreutz R.

Vasc Health Risk Manag. 2011;7:183-92. doi: 10.2147/VHRM.S16852. Review.

3.
4.

Efficacy and tolerability of amlodipine plus olmesartan medoxomil in patients with difficult-to-treat hypertension.

Chrysant SG, Lee J, Melino M, Karki S, Heyrman R.

J Hum Hypertens. 2010 Nov;24(11):730-8. doi: 10.1038/jhh.2010.5.

5.

Efficacy of amlodipine and olmesartan medoxomil in patients with hypertension: the AZOR Trial Evaluating Blood Pressure Reductions and Control (AZTEC) study.

Punzi H, Neutel JM, Kereiakes DJ, Shojaee A, Waverczak WF, Dubiel R, Maa JF.

Ther Adv Cardiovasc Dis. 2010 Aug;4(4):209-21. doi: 10.1177/1753944710374745.

PMID:
20519261
6.

Amlodipine besylate/olmesartan medoximil fixed combination for the treatment of hypertension.

Chrysant SG.

Expert Rev Cardiovasc Ther. 2009 Aug;7(8):887-95. doi: 10.1586/erc.09.85.

PMID:
19673666
7.

Efficacy of fixed-dose combination therapy in the treatment of patients with hypertension: focus on amlodipine/valsartan.

da Silva PM.

Clin Drug Investig. 2010;30(9):625-41. doi: 10.2165/11538440-000000000-00000. Review.

PMID:
20626210
8.
9.

Efficacy and safety of olmesartan medoxomil and hydrochlorothiazide compared with benazepril and amlodipine besylate.

Kereiakes DJ, Neutel JM, Punzi HA, Xu J, Lipka LJ, Dubiel R.

Am J Cardiovasc Drugs. 2007;7(5):361-72.

PMID:
17953475
10.

A titrate-to-goal study of switching patients uncontrolled on antihypertensive monotherapy to fixed-dose combinations of amlodipine and olmesartan medoxomil ± hydrochlorothiazide.

Weir MR, Hsueh WA, Nesbitt SD, Littlejohn TJ 3rd, Graff A, Shojaee A, Waverczak WF, Qian C, Jones CJ, Neutel JM.

J Clin Hypertens (Greenwich). 2011 Jun;13(6):404-12. doi: 10.1111/j.1751-7176.2011.00437.x.

11.

Olmesartan medoxomil plus amlodipine increases efficacy in patients with moderate-to-severe hypertension after monotherapy: a randomized, double-blind, parallel-group, multicentre study.

Barrios V, Brommer P, Haag U, Calderón A, Escobar C.

Clin Drug Investig. 2009;29(7):427-39. doi: 10.2165/00044011-200929070-00001.

PMID:
19499960
12.
13.

Efficacy of an amlodipine/olmesartan treatment algorithm in patients with or without type 2 diabetes and hypertension (a secondary analysis of the BP-CRUSH study).

Nesbitt SD, Shojaee A, Maa JF, Weir MR.

J Hum Hypertens. 2013 Jul;27(7):445-52. doi: 10.1038/jhh.2012.65.

PMID:
23254596
15.
16.
18.

Efficacy and safety of long-term treatment with the combination of amlodipine besylate and olmesartan medoxomil in patients with hypertension.

Chrysant SG, Oparil S, Melino M, Karki S, Lee J, Heyrman R.

J Clin Hypertens (Greenwich). 2009 Sep;11(9):475-82. doi: 10.1111/j.1751-7176.2009.00159.x.

20.

Effectiveness and tolerability of a fixed-dose combination of olmesartan and amlodipine in clinical practice.

Bramlage P, Wolf WP, Stuhr T, Fronk EM, Erdlenbruch W, Ketelhut R, Schmieder RE.

Vasc Health Risk Manag. 2010 Sep 7;6:803-11.

Items per page

Supplemental Content

Support Center